Disa trend is positive and strong... After hrs trade got strong buying too...imo, not too late to buyin too... If think n think for lower price, then the opportunities gone..... 😁 ...
bornloser ( Date: 14-Jan-2022 21:08) Posted:
|
My relative told me that I can get Saliva ART kits
In Malaysia for about RM 5
Anyone can confirm?
6 Dec(0.001): Disa-employee Stock Option/share Cheme: Grant of options pursuantto the DISA Employee Share Option Scheme 2021. 
8 Dec (0.002): Disa Annoucement: Disa signed licensing AGT with NUS and Singhealth to commercialise Saliva based covid 19 ART kits
13 Jan (0.008):  Disa-employee Stock Option/share Cheme: Grant of options pursuantto the DISA Employee Share Option Scheme 2021.
XX Jan: To be Continued...
8 Dec (0.002): Disa Annoucement: Disa signed licensing AGT with NUS and Singhealth to commercialise Saliva based covid 19 ART kits
13 Jan (0.008):  Disa-employee Stock Option/share Cheme: Grant of options pursuantto the DISA Employee Share Option Scheme 2021.
XX Jan: To be Continued...
LowLow12 ( Date: 14-Jan-2022 10:24) Posted:
|
License should be around the corner
Cny
Wait patiently for that
That really is the big license catalyst to move up.
9 looks like will eat up and start attacking 10 wall of resistance. Can it happen in the afternoon ? Or Monday ?
Let?s cross our fingers
Cny
Wait patiently for that
That really is the big license catalyst to move up.
9 looks like will eat up and start attacking 10 wall of resistance. Can it happen in the afternoon ? Or Monday ?
Let?s cross our fingers
giftedmind ( Date: 14-Jan-2022 09:43) Posted:
|
The $0.010 wall may not need to be broken down once a positive news is announced,
likely to open above $0.010 when it happens.
Anytime soon. - 
 
likely to open above $0.010 when it happens.
Anytime soon. - 
 
LowLow12 ( Date: 14-Jan-2022 08:23) Posted:
|
Imo.... The opportunities is here for eveyone (retaliers /bbs)... The company growing and huge opportunities ahead....in terms of its own products technologies and following on couple deal... 😁
LowLow12 ( Date: 14-Jan-2022 08:23) Posted:
|
Can the wall of 10 be broken down today ?
Let?s see what the BBs want to do after T4 yesterday.
Once 10 broken, ew 5 start
Fingers cross
Let?s see what the BBs want to do after T4 yesterday.
Once 10 broken, ew 5 start
Fingers cross
luckyfa ( Date: 13-Jan-2022 17:45) Posted:
|
Hope for Big breakthrough soon...' The company had Spoken!' 
Andrew123 ( Date: 13-Jan-2022 17:34) Posted:
|
Nice pre and post trading vol today
Who is Prof Soo Khee Chee?
They made him chairman of DLL
What can he bring to DLL?
71/72 years old already still working and passionate.
Very prominent surgeon
Has a passion to lead young researchers for new research
SingHealth's deputy CEO of research and education Soo Khee Chee to retire on Dec 31 2017
SINGAPORE - SingHealth's deputy group chief executive of research and education Soo Khee Chee, 67, will be retiring from SingHealth on Dec 31 after serving in public healthcare for nearly three decades.
In his role, Professor Soo steered collaborations with industry partners that led to improvements in clinical care. He also built a strong academic culture and laid a strong research foundation, SingHealth said in a statement on Wednesday (Dec 27).
He was instrumental in SingHealth's partnership with North Carolina's Duke University, and in bringing Duke-NUS Medical School to the Singapore General Hospital Campus.
Under his partnership with Duke-NUS, joint institutes such as the Academic Medicine Education Institute and Academic Medicine Research Institute were set up to facilitate learning and exchange.
Prof Soo was also the founding director at the National Cancer Centre Singapore (NCCS) since 1998, an appointment he relinquished with effect from Nov 26 this year.
Prof Soo led the growth of NCCS into its current position as a leading cancer institution both in Singapore and abroad.
He also had a passion for nurturing the next generation and led clinician scientists to achieve breakthroughs in research.
As a result, NCCS is recognised for its research in lymphoma, head and neck, nasopharyngeal, liver and lung cancers.
Prof Soo has won many awards, including the National Day Award Public Administration Gold Medal in 2003, the National Outstanding Clinician Mentor Award in 2008 and the President's Science and Technology Medal in 2011.
SingHealth group chief executive Ivy Ng said Prof Soo's "distinguished career in public healthcare has earned him respect as a visionary clinician-leader, outstanding surgeon and researcher".
"His foresight and mastery in building a sustainable research ecosystem and gaining philanthropic support has enabled the growth of the SingHealth Duke-NUS Academic Medical Centre," she said. "His passion for advancing medicine, developing people and most of all, patient care, is inspirational. We are pleased that he will continue to practise at NCCS and share his wealth of experience with us."
Prof Soo will continue to contribute as senior visiting consultant at NCCS and SingHealth, and remain as lead principal investigator in the Tan Chin Tuan Laboratory of Optical Imaging and Photodynamic Therapy of Cancer at NCCS.
In his place, Professor Wong Tien Yin will be appointed SingHealth's deputy group CEO in research and education with effect from Jan 1 next year.
Prof Wong, 49, is also medical director of the Singapore National Eye Centre and academic chair at the SingHealth Duke-NUS Ophthalmology and Visual Sciences Academic Clinical Programme.
He has previously served as SingHealth's group director in research as well as executive director of the Singapore Eye Research Institute, where he continues to chair the board.
Separately, blood cancer expert Associate Professor William Hwang Ying Khee, 50, was appointed medical director of NCCS and academic chair of the SingHealth Duke-NUS Oncology Academic Clinical Programme on Nov 26.
They made him chairman of DLL
What can he bring to DLL?
71/72 years old already still working and passionate.
Very prominent surgeon
Has a passion to lead young researchers for new research
SingHealth's deputy CEO of research and education Soo Khee Chee to retire on Dec 31 2017
SINGAPORE - SingHealth's deputy group chief executive of research and education Soo Khee Chee, 67, will be retiring from SingHealth on Dec 31 after serving in public healthcare for nearly three decades.
In his role, Professor Soo steered collaborations with industry partners that led to improvements in clinical care. He also built a strong academic culture and laid a strong research foundation, SingHealth said in a statement on Wednesday (Dec 27).
He was instrumental in SingHealth's partnership with North Carolina's Duke University, and in bringing Duke-NUS Medical School to the Singapore General Hospital Campus.
Under his partnership with Duke-NUS, joint institutes such as the Academic Medicine Education Institute and Academic Medicine Research Institute were set up to facilitate learning and exchange.
Prof Soo was also the founding director at the National Cancer Centre Singapore (NCCS) since 1998, an appointment he relinquished with effect from Nov 26 this year.
Prof Soo led the growth of NCCS into its current position as a leading cancer institution both in Singapore and abroad.
He also had a passion for nurturing the next generation and led clinician scientists to achieve breakthroughs in research.
As a result, NCCS is recognised for its research in lymphoma, head and neck, nasopharyngeal, liver and lung cancers.
Prof Soo has won many awards, including the National Day Award Public Administration Gold Medal in 2003, the National Outstanding Clinician Mentor Award in 2008 and the President's Science and Technology Medal in 2011.
SingHealth group chief executive Ivy Ng said Prof Soo's "distinguished career in public healthcare has earned him respect as a visionary clinician-leader, outstanding surgeon and researcher".
"His foresight and mastery in building a sustainable research ecosystem and gaining philanthropic support has enabled the growth of the SingHealth Duke-NUS Academic Medical Centre," she said. "His passion for advancing medicine, developing people and most of all, patient care, is inspirational. We are pleased that he will continue to practise at NCCS and share his wealth of experience with us."
Prof Soo will continue to contribute as senior visiting consultant at NCCS and SingHealth, and remain as lead principal investigator in the Tan Chin Tuan Laboratory of Optical Imaging and Photodynamic Therapy of Cancer at NCCS.
In his place, Professor Wong Tien Yin will be appointed SingHealth's deputy group CEO in research and education with effect from Jan 1 next year.
Prof Wong, 49, is also medical director of the Singapore National Eye Centre and academic chair at the SingHealth Duke-NUS Ophthalmology and Visual Sciences Academic Clinical Programme.
He has previously served as SingHealth's group director in research as well as executive director of the Singapore Eye Research Institute, where he continues to chair the board.
Separately, blood cancer expert Associate Professor William Hwang Ying Khee, 50, was appointed medical director of NCCS and academic chair of the SingHealth Duke-NUS Oncology Academic Clinical Programme on Nov 26.
Yes very promising
Resistance 10 wall if tear down will trigger a wave 5.
Just wait it out
Wait for those prominent doctors to bring DISA to Greater heights
Resistance 10 wall if tear down will trigger a wave 5.
Just wait it out
Wait for those prominent doctors to bring DISA to Greater heights
luckyfa ( Date: 13-Jan-2022 14:27) Posted:
|
LOL....ok, current situations look promising....
LowLow12 ( Date: 13-Jan-2022 14:22) Posted:
|
When hit ew 5 at 0.012/13
Sure alot ppl chase
Normal reaction
Sure alot ppl chase
Normal reaction
luckyfa ( Date: 13-Jan-2022 13:49) Posted:
|
Lets go go go....the company had spoken....sit doing nothing, opportuniites lost....
tankoksee ( Date: 13-Jan-2022 12:46) Posted:
|
I am queueing for buy not queueing for sell. This ticker can shoot to the moon at one day. the ones who on this train don' t set out at next stop yah
Sibehboeng ( Date: 13-Jan-2022 13:21) Posted:
|
For info
T4 670 lots done at 10 only
The rest at 9
We will know by end of today
220 mil due today
How many belong to bb and holders
504 pm we shall know
Lol
T4 670 lots done at 10 only
The rest at 9
We will know by end of today
220 mil due today
How many belong to bb and holders
504 pm we shall know
Lol
Sibehboeng ( Date: 13-Jan-2022 13:21) Posted:
|
Today is T+4 for those chased up to 9-10. Let' s see how many are holders. At this rate, contras still holding will be forced sell at 7.
I dont need cannon one. Got substance no need cannon
You can also show your 50 mil at any price.
I have placed mine at 0.03
 
You can also show your 50 mil at any price.
I have placed mine at 0.03
 
Newbie85 ( Date: 13-Jan-2022 13:06) Posted:
|
No 0.03 u don' t sell leh. Don' t big cannon ok. 
big cannon grow long nose
big cannon grow long nose
LowLow12 ( Date: 13-Jan-2022 13:05) Posted:
|
Yes i am definitely biased.
To show my confidence in DISA DLL, i will set my first target to sell 50mil at 0.030 now.
Let the share price wave 5 do the talking before CNY
Huat all believers!!!
To show my confidence in DISA DLL, i will set my first target to sell 50mil at 0.030 now.
Let the share price wave 5 do the talking before CNY
Huat all believers!!!
Newbie85 ( Date: 13-Jan-2022 13:01) Posted:
|